Page last updated: 2024-09-04

pannarin and Prostatic Neoplasms

pannarin has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cardile, V; Garbarino, J; Lombardo, L; Piovano, M; Russo, A; Vanella, L	1

Other Studies

1 other study(ies) available for pannarin and Prostatic Neoplasms

Article	Year
Pannarin inhibits cell growth and induces cell death in human prostate carcinoma DU-145 cells. Anti-cancer drugs, 2006, Volume: 17, Issue:10 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzoates; Benzoxepins; Carcinoma; Caspase 3; Cell Death; Cell Growth Processes; Cell Survival; Depsides; DNA Fragmentation; Humans; L-Lactate Dehydrogenase; Lichens; Male; Models, Biological; Prostatic Neoplasms; Reactive Oxygen Species; Tumor Cells, Cultured	2006

Article

Year

Pannarin inhibits cell growth and induces cell death in human prostate carcinoma DU-145 cells.

Anti-cancer drugs, 2006, Volume: 17, Issue:10

Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzoates; Benzoxepins; Carcinoma; Caspase 3; Cell Death; Cell Growth Processes; Cell Survival; Depsides; DNA Fragmentation; Humans; L-Lactate Dehydrogenase; Lichens; Male; Models, Biological; Prostatic Neoplasms; Reactive Oxygen Species; Tumor Cells, Cultured

2006